Advertisement

The Scientist

» drug development

Most Recent

image: FDA May Fast-track Needed Drugs

FDA May Fast-track Needed Drugs

By | November 18, 2011

New congressional proposals would allow drug makers to bypass traditional clinical trial requirements for drugs that address rare diseases.

0 Comments

image: Prescription Drug Pollutants

Prescription Drug Pollutants

By | November 7, 2011

Are pharmaceuticals in the environment affecting human health?

0 Comments

image: Spider Bites for Cures?

Spider Bites for Cures?

By | October 31, 2011

Researchers scan the molecules in spider venom for anti-cancer effects in tissue culture.

0 Comments

image: Drug Shortages Plague Research

Drug Shortages Plague Research

By | October 5, 2011

Dwindling stocks in more than a dozen cancer drugs are delaying clinical trials.

0 Comments

image: FDA to Revamp Rare Disease Efforts

FDA to Revamp Rare Disease Efforts

By | September 12, 2011

The US government agency vows to improve the way it facilitates the development and approval of drugs for orphan diseases.

3 Comments

image: Detecting New Synthetic Drugs

Detecting New Synthetic Drugs

By | September 1, 2011

Forensic labs in the United States should be better equipped to identify a new crop of recreational drug mimics.

0 Comments

image: Data-Mining for New Treatments

Data-Mining for New Treatments

By | August 18, 2011

A new database helps scientist predict new uses for existing drugs.

3 Comments

image: FDA's Biomarker and Device Advice

FDA's Biomarker and Device Advice

By | August 18, 2011

The US federal agency issues draft rules to guide medical device makers and those hoping to register biomarkers.

0 Comments

image: Facebook Forces Pharma to Show Comments

Facebook Forces Pharma to Show Comments

By | August 17, 2011

The social media site enforces its rule that pages should allow social interaction through comments, even on drug company pages.

0 Comments

image: The Father of Trial Randomization Dies

The Father of Trial Randomization Dies

By | August 15, 2011

Statistician Paul Meier, who championed the random assignment of patients to treatment groups in clinical trials, changed the way the researchers test experimental drugs.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
CEM
CEM
Advertisement
NeuroScientistNews
NeuroScientistNews
Life Technologies